A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 18, Issue 5, Pages 736-742
Publisher
American Society for Microbiology
Online
2011-03-03
DOI
10.1128/cvi.00542-10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
- (2011) P. T. Beernink et al. JOURNAL OF IMMUNOLOGY
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- (2011) David M. Vu et al. VACCINE
- A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
- (2011) P.B. Keiser et al. VACCINE
- Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
- (2010) P. Bonvehi et al. Clinical and Vaccine Immunology
- Review of Meningococcal Group B Vaccines
- (2010) Dan M. Granoff CLINICAL INFECTIOUS DISEASES
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process
- (2010) Bas van de Waterbeemd et al. VACCINE
- A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA
- (2010) Paul B. Keiser et al. VACCINE
- Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
- (2010) Wendell D. Zollinger et al. VACCINE
- Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
- (2009) V. Weynants et al. INFECTION AND IMMUNITY
- Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter
- (2009) F. Oriente et al. JOURNAL OF BACTERIOLOGY
- Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis
- (2009) Ellen Murphy et al. JOURNAL OF INFECTIOUS DISEASES
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa
- (2009) P. T. Beernink et al. JOURNAL OF INFECTIOUS DISEASES
- The modular architecture of meningococcal factor H-binding protein
- (2009) P. T. Beernink et al. MICROBIOLOGY-SGM
- Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
- (2009) Rolando Pajon et al. VACCINE
- Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2
- (2008) O. Koeberling et al. Clinical and Vaccine Immunology
- Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein
- (2008) P. T. Beernink et al. INFECTION AND IMMUNITY
- Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years
- (2008) Y. Galloway et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Bactericidal Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Factor H–Binding Protein and Genetically Attenuated Endotoxin
- (2008) Oliver Koeberling et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More